Assessing the therapeutic effect of probiotics on individuals in mild cognitive impairment.
- Conditions
- Mental and Behavioural Disorders
- Registration Number
- PACTR202305650866475
- Lead Sponsor
- WESTERN SYDNEY UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
•The subject is between 50-75 years old.
•The subject is clinically diagnosed with Mild cognitive impairment by the Neurologist.
•The subject's MoCA score is between 10-26.
•The subject can cooperate to perform cognitive function tests.
•The subject has dependable caregivers who can record the compliance of taking probiotics and any physical conditions.
•The subject or family members signed the informed consent form and answered the questionnaire.
•The subject has dementia caused by other reasons, such as brain trauma, tumour, infection, epilepsy, etc.
•The subject has consumed probiotic-related products (probiotic powder, yoghurt or other fermented foods) within the past 1 month.
•The subject has participated in clinical trials of other dementia medications in the past 1 month.
•The subject is assessed for dementia caused by vitamin B12 deficiency or thyroid abnormalities.
•The subject suffers from mental illness, severe depression, schizophrenia, drug addiction, and alcohol addiction.
•The subject has Parkinson's disease.
•The subject is assessed to have severe metabolic and liver and kidney dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method